Podcast appearances and mentions of donna ryan

In this special series on obesity, our host, Dr. Neil Skolnik, discusses the obesity epidemic with some of the foremost experts in the world. In Part 2 of the series, Dr. Skolnik is joined by Drs. Deborah Horn, Thomas Wadden, and Donna Ryan. Together, they discuss, in detail, approaches to obesity including lifestyle, medications and bariatric surgery. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: four episodes of Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals; as well as three episodes of its sister podcast, Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Thomas Wadden PhD,  is a Professor of Psychology in Psychiatry at the Perelman School of Medicine at the University of Pennsylvania. He is the former director of the Center for Weight and Eating Disorders at Penn.   Donna Ryan, MD Professor emeritus at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. Deborah B. Horn, DO, MPH, Medical Director for the UT Center of Obesity Medicine and Metabolic Performance; Fellowship Program Director, Allison Family Foundation Fellowship in Clinical Obesity Medicine and Metabolism, McGovern Medical School Selected references:  STEP-1 Trial (Semaglutide) – Wilding J,  Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021; 384(11), 989-1002. DOI: 10.1056/NEJMoa2032183 SURMOUNT-1 Trial (Tirzepatide) - Jastreboff, A.M., Aronne, L.J., Ahmad, N.N., et. al. Tirzepatide Once Weekly for the Treatment of Obesity. The New England Journal of Medicine. 2022; 387(3), 205-216. DOI: 10.1056/NEJMoa2206038 STEP – 4 Trial - Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021; 325(14), 1414-1425. DOI: 10.1001/jama.2021.3224 SURMOUNT-4 Trial - Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. 2024;331(1):38–48. doi:10.1001/jama.2023.24945 Diabetes Prevention Program Trial:  Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393– 403  Look Ahead Trial: Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145–54.

CME credits: 1.00 Valid until: 03-01-2025 Claim your CME credit at https://reachmd.com/programs/cme/application-of-motivational-interviewing-and-shared-decision-making-techniques-in-obesity-management/16385/ Experts review best practices for the incorporation of motivational interviewing and shared decision-making strategies to improve the treatment of obesity. Tune in with Dr. Megan Adelman, Clinical Pharmacist of Family Medicine at Cleveland Clinic Akron General in Ohio, Dr. Donna Ryan, Professor Emerita at Pennington Biomedical Research Center in Baton Rouge, Louisiana, and Daniel Zalinov, Physician Assistant who specializes in Internal Medicine at Atrium Health in Charlotte, North Carolina. =

CME credits: 1.00 Valid until: 27-12-2024 Claim your CME credit at https://reachmd.com/programs/cme/treating-obesity-as-a-chronic-disease/16389/ Experts review guideline-recommended criteria for diagnosis and treatment of obesity and describe best practices for prioritization of obesity management. Tune in to learn more with Dr. Caroline Apovian, Co-Director at Center for Weight Management and Wellness at Brigham and Women's Hospital in Boston, Dr. Donna Ryan, Professor Emerita at Pennington Biomedical Research Center in Baton Rouge, Louisiana, and Dr. Susan M. Tiso, Retired Family Nurse Practitioner from Family Medicine at the University of California, Irvine.=

In this podcast, experts Donna Ryan, MD, and Renslow Sherer, MD, discuss how to manage the health risks posed by COVID-19 infection and long COVID in individuals with metabolic syndrome or obesity.First, Dr Ryan presents an overview of the relationship between COVID-19 and weight, including the mechanisms of how obesity may drive COVID-19 disease and how COVID-19 may in turn worsen obesity, through both immunologic and social or societal drivers.Dr Ryan also discusses the relationship between obesity and the risk for long COVID.In his segment, Dr Sherer discusses COVID-19 vaccination and antiviral therapy within the context of obesity and metabolic syndrome. Dr Sherer also delves into detail on how obesity-related risk factors or comorbidities may affect treatment decisions and presents strategies on individualizing treatment, including in patients with long COVID.This episode includes results from several reviews and meta-analyses examining the relationship between vaccination, as well as an observational study investigating the impact of nirmatrelvir/ritonavir therapy on long COVID in vaccinated patients.Presenters:Donna Ryan, MDProfessor Emerita Pennington Biomedical Research Center New Orleans, Louisiana Renslow Sherer, MDDirector of the International HIV Training Center Professor of MedicineInfectious Diseases and Global Health Department of Medicine University of Chicago Department of Medicine Chicago, IllinoisContent based on an online CME program supported by independent educational grants from Pfizer.Link to full program:https://bit.ly/46yuChS

CME credits: 0.25 Valid until: 26-05-2024 Claim your CME credit at https://reachmd.com/programs/cme/case-challenge-in-obesity-medical-management/15359/ Addressing the health issues of your patients with obesity can present a challenge. How can you initiate the conversation and effectively emphasize the benefits of weight loss? Join Drs. Charles Vega and Donna Ryan as they review a case of obesity and use evidence-based medicine to develop a patient-centric treatment plan.=

CME credits: 0.25 Valid until: 26-05-2024 Claim your CME credit at https://reachmd.com/programs/cme/what-you-need-to-know-about-weight-loss-medications/15360/ Obesity is a chronic, progressive disease which has often been overlooked by physicians, leaving a considerable proportion of people with obesity underdiagnosed and inappropriately managed. Join Drs. Charles Vega and Donna Ryan as they break down the pathophysiology of obesity and discuss currently available weight-loss medications.=

How can you change the paradigm on obesity as a disease? In this episode, Drs Robert Kushner and Donna Ryan dig into the science, speak about bias within the healthcare system, and advocate for better patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982631). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Comparison of Weight-Loss Diets With Different Compositions of Fat, Protein, and Carbohydrates https://pubmed.ncbi.nlm.nih.gov/19246357/ Look AHEAD (Action for Health in Diabetes): Design and Methods for a Clinical Trial of Weight Loss for the Prevention of Cardiovascular Disease in Type 2 Diabetes https://pubmed.ncbi.nlm.nih.gov/14500058/ First versus Repeat Treatment With a Lifestyle Intervention Program: Attendance and Weight Loss Outcomes https://pubmed.ncbi.nlm.nih.gov/18711387/ Effects of Dietary Patterns on Blood Pressure: Subgroup Analysis of the Dietary Approaches to Stop Hypertension (DASH) Randomized Clinical Trial https://pubmed.ncbi.nlm.nih.gov/9989541/ The Role of Gut Hormones in Diet-Induced Weight Change: A Systematic Review https://pubmed.ncbi.nlm.nih.gov/28934819/ Adult Obesity Facts https://www.cdc.gov/obesity/data/adult.html Obesity Emergence in the Pacific Islands: Why Understanding Colonial History and Social Change Is Important https://pubmed.ncbi.nlm.nih.gov/25166024/ The Prevalence of Overweight and Obesity in an Adult Kuwaiti Population in 2014 https://pubmed.ncbi.nlm.nih.gov/31338067/ Obesity in Mexico, Prevalence and Trends in Adults. Ensanut 2018-19. https://pubmed.ncbi.nlm.nih.gov/33620965/

This week on the Gaining Health podcast, we interview the Queen of Obesity Medicine herself, Dr. Donna Ryan! Dr. Ryan and Karli discuss how it was that Dr. Ryan became involved with many of the sentinel nutrition and obesity studies, how obesity management has progressed throughout the years, potential concerns with the newer antiobesity medications, and Dr. Ryan tackles some of the biggest questions about how to prevent the tsunami of obesity and obesity-related complications that will come our way unless we change course.Dr. Donna Ryan is professor emerita of Pennington Biomedical Research Center, a campus of Louisiana State University in Baton Rouge, where, until retirement, she directed clinical research for 22 years. Her own research includes participation on the teams that developed and executed studies such as Dietary Approaches to Stop Hypertension (DASH), Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost), Diabetes Prevention Program (DPP) and Action for Health in Diabetes (Look AHEAD). Dr. Ryan's continuing interests focus on the translation of effective weight management into primary care practices. She is the past president of The Obesity Society and has served as panel co-chair to revise the NIH-supported evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults. Her scholarly activities include authorship of more than 200 original publications and 45 books, chapters and reviews, primarily in the field of obesity.Support the showThe Gaining Health Podcast will release a new episode monthly, every second Wednesday of the month. Episodes including interviews with obesity experts as well as scientific updates and new guidelines for the management of obesity.If you're a clinician or organization looking to start or optimize an obesity management program, and you want additional support and resources, check out the Gaining Health website! We offer monthly and annual Memberships, which include live group coaching, a community forum to ask questions and post resources, pre-recorded Master Classes, digital resources inlcuding patient education materials and office forms, and much more! We also sell our popular Gaining Health products, including a book on developing an obesity management program, editable forms and templates, and patient education materials in our Gaining Health Shop! If you are loving this podcast, please consider supporting us on Patreon

In this podcast, expert clinicians discuss topics related to Getting Engaged in Obesity Care and answer audience questions from the Obesity Forum activities.

Donna Ryan, MD, FTOS, MABOM - Practical Makes Perfect: Pragmatic Guidance for Implementation of GLP-1 RAs Across the Trajectory of T2D

Donna Ryan, MD, FTOS, MABOM - Practical Makes Perfect: Pragmatic Guidance for Implementation of GLP-1 RAs Across the Trajectory of T2D

Donna Ryan, MD, FTOS, MABOM - Practical Makes Perfect: Pragmatic Guidance for Implementation of GLP-1 RAs Across the Trajectory of T2D

Donna Ryan, MD, FTOS, MABOM - Practical Makes Perfect: Pragmatic Guidance for Implementation of GLP-1 RAs Across the Trajectory of T2D

CME credits: 0.50 Valid until: 15-09-2023 Claim your CME credit at https://reachmd.com/programs/cme/why-weight-loss-should-be-the-primary-goal-of-treatment-in-type-2-diabetes-care/14130/ Dropping 15% or more of body weight has a greater disease-modifying effect than any other glucose-lowering intervention. Join Drs. Donna Ryan and Juan Pablo Frias as they discuss implementing an upstream intervention to weight loss and newer drugs (GIP agonists, GLP-1 receptor agonists, SGLT2 inhibitors) to help your patients experience improved effects earlier and for a longer duration. Tune in to find out how the novel dual GIP and GLP-1 receptor antagonist tirzepatide could fit into your therapeutic strategies.

"It's been over twenty years since clinical inertia was coined a term, and since that time, experts have debated on how to define it, and where and when it exists across the treatment paradigm. Every year, scores of information cross HCP's desks on clinical inertia, but when it comes to your patients, how do you determine whether your decisions to delay treatment intensification are clinical inertia or 'appropriate inaction?' And what about obesity? Individualizing treatment targets for patients with diabetes requires a comprehensive approach to minimize associated morbidity and mortality. Because most patients with T2DM are overweight or obese, effective glucose control and weight loss are needed to reduce cardiovascular risk factors and other complications of T2DM. However, misconceptions about the causes and mechanisms of obesity, and the false assumption that patients can manage their weight with simple behavioral modifications, contribute to ongoing clinical inertia in patients with diabetes." Visit the CME activity and Clinical Inertia Assessment Tool. Donna Ryan is professor emerita at Pennington Biomedical in Baton Rouge, LA. Robert Kushner is professor of medicine and medicine education at Northwestern University Feinberg School of Medicine, and director of the Center for Lifestyle Medicine in Chicago, IL. This episode is sponsored by the Academy for Continued Healthcare Learning, an independently owned and operated full-service medical education company that has been developing certified health care education for nearly twenty years. Visit the CME activity and Clinical Inertia Assessment Tool.

Ep 043: Banned From Baby Showers Today we are meeting with the wonderful, awesome, amazing Donna Ryan to discuss the release of her book Banned From Baby Showers! If this title intrigues you as much as it did for us then you will want to tune in to hear the story behind the name and other fun behind the scenes from her incredible book! And if you didn't know, Donna is the Founder of Birth Boot Camp so of course, we think this a MUST read. You can find her book at bannedfrombabyshowers.com if you are interested in learning more.

In this episode, Obesity medicine specialist and OMA clinical education director, Dr. Nicholas Pennings interviews Dr. Donna Ryan, highlighted speaker from Obesity Medicine 2021 - Virtual, about alternatives to weight promoting medications. Topics covered include, most commonly prescribed medications that are associated with weight gain, the variable impact of individual medications on weight, strategies that providers can use to mitigate weight effects when a patient needs to be on a medication that promotes weight gain, and resources providers can use to learn more about medications that cause weight gain and their alternatives. You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org/podcasts. Episode Guests Nicholas Pennings, DO, FOMA, Dipl. ABOM Donna Ryan, MD Resources Mentioned Do No Harm Alternatives to Weight Promoting Medications

Special guest, Donna Ryan, bring an encouraging word that is needed for the church in the last days.

Last week was Mental Illness Awareness Week, and a few days ago the world also celebrated World Mental Health Day. To bring awareness to this and the stigma around mental health, this episode we are joined by psychology professional Donna Ryan! Donna shares her knowledge about what mental health is, how to cope with it, and more on this episode of Words with WMN.

Hear Aaron's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

Hear host Aaron Lohr's talk with Donna Ryan from Pennington Biomedical about the latest developments in obesity treatment. For more information, including helpful links and other episodes, visit our website at https://www.endocrine.org/podcast.

MVPs and experts who have built ConfigMgr community tools share about their development process, the comradery with other tool developers, and their favorite ConfigMgr community tools in this special podcast party edition of E3 from MMS Jazz. Guests include: David Segura, Steven Hosking, Adam Gross, Jordan Benzing, Donna Ryan, Jörgen Nilsson, Bryan Dam, Maurice Daly, and Jan Ketil Skanke.

Learn more about population health at DiabetesEducator.org/PopulationHealthLearn more about AADE's Vision for the future of diabetes care at DiabetesEducator.org/Vision

In this podcast, Donna Ryan, MD, MABOM, talks about evaluating obesity medications, her tips for choosing the right medication for the right patient, and medications that are on the horizon. This is also the topic of her session at our Cardiometabolic Risk Summit 2019 in October. More at: www.consultant360.com/cardiology.

15 Minute History Podcast • Ask A Slave with Azie Mira Dungey and Slate • Donna Ryan • Julia Binter • Conclusion - An overview of Unit 6: Facilitating Difficult Conversation in Public History, with Readings on Azie Mira Dungey at Ask a Slave and Diane Ramey Berry, and by Donna Ryan and Julia Binter, along with information on our last class project. - Featuring host Dr. Kera Lovell from the University of Utah, Asia Campus.

Host: John J. Russell, MD Dr. John Russell speaks with Dr. Donna Ryan, Professor Emeritus at Pennington Biomedical Research Center in Baton Rouge Louisiana. Dr. Ryan serves as co-Chair of the panel to revise the NIH-supported evidence-based Guidelines on the Evaluation and Management of Overweight and Obesity in Adults. She is past President of The Obesity Society and currently Associate Editor in Chief of the journal, Obesity.